IRLAB Therapeutics AB (publ) announced that at its Annual General Meeting held on may 11, 2022, An van Es-Johansson and Catharina Gustafsson Wallich were elected as new Board members.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.6 SEK | +1.63% | -3.70% | +108.00% |
27/05 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
27/05 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.00% | 76.43M | |
+42.60% | 748B | |
+32.95% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.75% | 245B | |
+8.47% | 211B | |
-4.58% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- IRLAB Therapeutics AB Approves Board Appointments